Sitagliptin oral tablet is a prescription medication used to treat high blood sugar levels caused by type 2 diabetes. Sitagliptin oral tablet is available as the brand-name drug Januvia. It’s ...

Sitagliptin dose-dependently protects rat kidneys from acute IR injury via upregulation of serum GLP-1 and GLP-1 receptor expression in kidneys.

Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...

Adults with type 2 diabetes who were hospitalized with COVID-19 in northern Italy had a lower mortality rate and better health outcomes when treated with the DPP-IV inhibitor sitagliptin ...

UPDATED // The TECOS study showed sitagliptin was not associated with any signal of cardiovascular risk and, importantly, absolutely no increase in the risk of heart failure, a signal that has ...

A secondary analysis of data from the TECOS trial of sitagliptin finds that the drug does not affect the risk for heart failure hospitalization or related adverse ...

Diabetes type 2 arises slowly after years of prediabetes. The diabetes drug sitagliptin improves many of the problems that mark prediabetes, including high levels of blood sugar after meals and ...

Switching from sitagliptin to Victoza (liraglutide ; Novo Nordisk), in combination with metformin, showed superior HbA1c reductions vs. continuing with sitagliptin in adults with type 2 diabetes.

"Vildagliptin and sitagliptin affected incretin hormones, glucose concentrations, insulin, and glucagon secretion in a similar manner," the authors write.

Sitagliptin and glipizide monotherapy is safe and effective in patients with type 2 diabetes and end-stage renal disease (ESRD) requiring dialysis, researchers reported online ahead of print in ...